Cerenion is happy to introduce its partner, Elmiko Biosignals, a Polish medical technology company with decades of experience in EEG.
High-quality and reliable hardware is a vital part of the C-Trend EEG Station. When selecting a supplier for the hardware components, deep EEG expertise and proven medical device manufacturing capabilities — backed by EN ISO 13485:2016 certification — were essential, given the demanding requirements of clinical use. Elmiko Biosignals stood out as a natural choice.
With extensive experience in EEG, electronics, and medical technology, Elmiko brings valuable specialist expertise to the collaboration. Its EEG amplifier technology combines excellent signal quality with robust engineering and a design suited to everyday clinical use. Elmiko’s own EEG systems support applications ranging from routine clinical diagnostics to long-term neonatal and ICU monitoring (aEEG/CFM), giving the company a practical understanding of what reliable hardware needs to deliver in demanding clinical settings.
“Choosing the right partners is essential to how we build C-Trend for the future. Elmiko combines deep EEG expertise with the quality and reliability we require from the hardware at the heart of our solution. Their experience and commitment made them a strong choice for C-Trend, and we look forward to developing our collaboration over the long term,” says Dr. Jukka Kortelainen, CEO and co-founder of Cerenion.
“We are thrilled about our collaboration with Cerenion. Quality, reliability, and continuous development have guided our work in EEG technology for nearly five decades, and we are pleased to bring that experience to the C-Trend EEG Station,” says Paweł Niedbalski, President of Elmiko Biosignals.
With Elmiko as a trusted hardware supplier, Cerenion continues its mission to make EEG monitoring in acute healthcare easier and more accessible than ever before.
